Prostate Cancer Early Detection, Version 2.2015

    Peter R. Carroll, J. Kellogg Parsons, Gerald L. Andriole, Robert R. Bahnson, Daniel A. Barocas, Erik P. Castle, William J. Catàlona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth Etzioni, Thomas Farrington, George P. Hemstreet, Mark H. Kawachi, Paul H. Lange, Kevin R. Loughlin, William T. Lowrance, Paul Maroni, James L. Mohler, Todd M. Morgan, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence Shaneyfelt, Marc C. Smaldone, Geoffrey A. Sonn, Preston Sprenke, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, Deborah A. Freedman-Cass
    TLDR The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.
    The 2015 NCCN Guidelines for Prostate Cancer Early Detection outlined a strategy for screening and evaluating prostate cancer to maximize the detection of potentially curable cases while minimizing unnecessary procedures and the detection of indolent disease. These guidelines were intended for healthy men who chose to participate in early detection efforts, addressing the spectrum of prostate cancer from nonaggressive to aggressive forms. The focus was on identifying cases that posed a risk if left undetected, thereby balancing the benefits of early detection with the risks of overdiagnosis and overtreatment.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Research

    1 / 1 results